◄ back to all posts
Financial data and stock pages provided by
Fintel.io
Noah Didn’t Yield To FOMO, Neither Should You
May 5, 2021
The Adverse Consequences Of A $15/Hour Wage Hike
May 3, 2021
◄ back to all posts
MRNA: Moderna Inc Stock
Written by | Jul 6, 2018
SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 63,838.90 |
| Enterprise Value ($M) | 58,220.23 |
| Book Value ($M) | 3,838.00 |
| Book Value / Share | 9.58 |
| Price / Book | n/a |
| NCAV ($M) | 2,847.00 |
| NCAV / Share | 7.11 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.29 |
| Return on Assets (ROA) | -0.47 |
| Return on Equity (ROE) | -0.64 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.33 |
| Current Ratio | 1.39 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 11,703.00 |
| Assets | 12,694.00 |
| Liabilities | 8,856.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 803.39 |
| Operating Income | -763.14 |
| Net Income | -747.06 |
| Earnings Per Share Basic And Diluted | -1.96 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 2,026.97 |
| Cash from Investing | -1,671.93 |
| Cash from Financing | -1,671.93 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Baillie Gifford & Co | 11.18 | 83.82 | |
| 13G/A | Flagship Ventures Fund IV General Partner LLC | 8.40 | -35.02 | |
| 13G/A | Bancel Stephane | 7.09 | -9.30 | |
| 13G/A | Astrazeneca Plc | 0.00 | ||
| 13G/A | Vanguard Group Inc | 5.91 | 34.95 | |
| 13G | BlackRock Inc. | 5.20 | ||
| 13G/A | Viking Global Investors Lp | 1.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| Quarterly Report – 10-Q | ||
| Annual Report – 10-K | ||
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,171,018 | 8,086,700 | 14.48 | |
| 1,277,557 | 8,803,300 | 14.51 | |
| 1,827,386 | 11,952,000 | 15.29 | |
| 5,262,504 | 29,662,300 | 17.74 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| MORF – Morphic Holding Inc | MREO – Mereo BioPharma Group plc |
| MRKR – Marker Therapeutics Inc | MRNS – Marinus Pharmaceuticals Inc |
| MRSN – Mersana Therapeutics Inc |
Financial data and stock pages provided by
Fintel.io
2018/07/06
Also Read
